Comerica Bank
EDIT icon

Comerica Bank’s Editas Medicine EDIT Stock Holding History

Comerica Bank’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$111 Hold
54
– – ﹤0.01% 3684
2025
Q3 		$187 Sell
54
-40
-43% -$112 ﹤0.01% 3681
2025
Q2 		$207 Hold
94
– – ﹤0.01% 3648
2025
Q1 		$109 Sell
94
-1,036
-92% -$1.52K ﹤0.01% 3662
2024
Q4 		$1.44K Buy
1,130
+966
+589% +$2.46K ﹤0.01% 3526
2024
Q3 		$559 Buy
164
+70
+74% +$305 ﹤0.01% 3611
2024
Q2 		$439 Hold
94
– – ﹤0.01% 3627
2024
Q1 		$698 Sell
94
-705
-88% -$5.86K ﹤0.01% 3650
2023
Q4 		$8.09K Sell
799
-15,103
-95% -$133K ﹤0.01% 3201
2023
Q3 		$124K Buy
+15,902
New +$136K ﹤0.01% 2402

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Comerica Bank's EDIT Position: Q4 2025 in Review

Comerica Bank held its Editas Medicine (EDIT) position steady in Q4 2025 at 54 shares worth $111. The position accounts for ﹤0.01% of the portfolio, ranked #3684.

Comerica Bank first reported a position in EDIT in Q3 2023 and has held it in 10 quarters since. The position peaked at $124K in Q3 2023. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Comerica Bank held 54 shares of Editas Medicine worth $111 as of Q4 2025.
  • Comerica Bank left its Editas Medicine share count unchanged in Q4 2025.
  • Editas Medicine made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3684 holding.
  • Comerica Bank first reported a position in Editas Medicine in Q3 2023 and has held it in 10 quarters since.
  • Comerica Bank's Editas Medicine position peaked at $124K in Q3 2023.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.